Chronic herpes simplex virus type-2 infection and HIV viral load

被引:43
作者
Duffus, WA
Mermin, J
Bunnell, R
Byers, RH
Odongo, G
Ekwaru, P
Downing, R
机构
[1] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA
[2] S Carolina Dept Hlth & Environm Control, Columbia, SC 29201 USA
[3] CDC, Natl Ctr HIV STD & TB, Global AIDS Program, CDC Uganda, Entebbe, Uganda
[4] Uganda Virus Res Inst, Entebbe, Uganda
关键词
herpes simplex virus type-2; human immunodeficiency virus; Uganda; HIV viral load; CD4+cell count;
D O I
10.1258/095646205774763298
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
By December 2003, the estimated adult HIV/AIDS prevalence rate in sub-Saharan Africa was 7.5-8.5%, and rates of herpes simplex virus type-2 (HSV-2) infection among adults aged > 30 years ranged from 60% to 82%. However, little is known about the natural history of HIV/HSV-2 co-infection in this population. We evaluated HIV viral load and CD4+ cell counts among persons with and without chronic HSV-2 co-infection in a cross-sectional study of HIV-infected persons not receiving antiretroviral therapy. HSV-2 and HIV co-infection was associated with a 0.3 log copies/mL higher HIV viral load compared with persons without HSV-2 infection (P=0.014). Chronic HSV-2 infection may have a negative effect on the clinical course of persons with HIV.
引用
收藏
页码:733 / 735
页数:3
相关论文
共 20 条
[1]   Plasma HIV viral load in relation to season and to Plasmodium falciparum parasitaemia [J].
Ariyoshi, K ;
van der Loeff, MS ;
Berry, N ;
Jaffar, S ;
Whittle, H .
AIDS, 1999, 13 (09) :1145-1146
[2]  
Calistri A, 1999, J ACQ IMMUN DEF SYND, V21, P90
[3]   Human immunodeficiency virus infection and genital ulcer disease in South Africa -: The herpetic connection [J].
Chen, CY ;
Ballard, RC ;
Beck-Sague, CM ;
Dangor, Y ;
Radebe, F ;
Schmid, S ;
Weiss, JB ;
Tshabalala, V ;
Fehler, G ;
Htun, Y ;
Morse, SA .
SEXUALLY TRANSMITTED DISEASES, 2000, 27 (01) :21-29
[4]  
Emonyi IW, 2000, E AFR MED J, V77, P428
[5]  
FERRE F, 1995, J ACQUIRED IMMUNE S2, V10, P51
[6]   TRANSACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT SEQUENCE BY DNA VIRUSES [J].
GENDELMAN, HE ;
PHELPS, W ;
FEIGENBAUM, L ;
OSTROVE, JM ;
ADACHI, A ;
HOWLEY, PM ;
KHOURY, G ;
GINSBERG, HS ;
MARTIN, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) :9759-9763
[7]   GENITAL ULCERATION AS A RISK FACTOR FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
GREENBLATT, RM ;
LUKEHART, SA ;
PLUMMER, FA ;
QUINN, TC ;
CRITCHLOW, CW ;
ASHLEY, RL ;
DCOSTA, LJ ;
NDINYAACHOLA, JO ;
COREY, L ;
RONALD, AR ;
HOLMES, KK .
AIDS, 1988, 2 (01) :47-50
[8]   COINFECTION AND SYNERGY OF HUMAN IMMUNODEFICIENCY VIRUS-1 AND HERPES-SIMPLEX VIRUS-1 [J].
HENG, MCY ;
HENG, SY ;
ALLEN, SG .
LANCET, 1994, 343 (8892) :255-258
[9]   The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration [J].
Hoffman, IF ;
Jere, CS ;
Taylor, TE ;
Munthali, P ;
Dyer, JR ;
Wirima, JJ ;
Rogerson, SJ ;
Kumwenda, N ;
Eron, JJ ;
Fiscus, SA ;
Chakraborty, H ;
Taha, TE ;
Cohen, MS ;
Molyneux, ME .
AIDS, 1999, 13 (04) :487-494
[10]   Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: A meta-analysis of randomized individual patient data [J].
Ioannidis, JPA ;
Collier, AC ;
Cooper, DA ;
Corey, L ;
Fiddian, AP ;
Gazzard, BG ;
Griffiths, PD ;
Contopoulos-Ioannidis, DG ;
Lau, J ;
Pavia, AT ;
Saag, MS ;
Spruance, SL ;
Youle, MS .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :349-359